We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$11.9B
AUM Growth
+$2.85B
(+31%)
Cap. Flow
+$2.52B
Cap. Flow
% of AUM
21.15%
Top 10 Holdings %
Top 10 Hldgs %
66.56%
Holding
140
New
48
Increased
33
Reduced
16
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$647M |
| 2 |
K
Kellanova
K
|
+$184M |
| 3 |
Nucor
NUE
|
+$173M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$161M |
| 5 |
HEES
H&E Equipment Services
HEES
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$501M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$473M |
| 3 |
ALTM
Arcadium Lithium plc
ALTM
|
+$141M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.2M |
| 5 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
+$82.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.86% |
| 2 | Materials | 9.38% |
| 3 | Healthcare | 8.13% |
| 4 | Energy | 7.96% |
| 5 | Technology | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
26
DELISTED
Discover Financial Services
DFS
| $87.1M | 0.73% |
510,000
-25,000
| -5% | -$4.57M |
|
|
AZEK
27
DELISTED
The AZEK Co
AZEK
| $75.4M | 0.63% |
+1,541,842
| New | +$73M |
|
|
JNPR
28
PUT
DELISTED
Juniper Networks
JNPR
| $74.5M | 0.63% |
2,058,000
-920,000
| -31% | -$33.7M |
|
29
Carnival Corporation Ltd
CCL
$39.7B
| $73.2M | 0.61% |
3,750,000
+2,400,000
| +178% | +$57.1M |
|
|
ESGR
30
DELISTED
Enstar Group
ESGR
| $67.4M | 0.57% |
+202,862
| New | +$66.9M |
|
31
Surgery Partners
SGRY
$2.03B
| $65.1M | 0.55% |
2,742,000
+2,317,000
| +545% | +$54.8M |
|
|
IPG
32
DELISTED
Interpublic Group of Companies
IPG
| $63.6M | 0.53% |
2,340,000
+1,990,000
| +569% | +$54.6M |
|
|
33
PUT
Nucor
NUE
$62.1B
| $60.8M | 0.51% |
+505,000
| New | +$65.1M |
|
|
PLYA
34
DELISTED
Playa Hotels & Resorts
PLYA
| $59.7M | 0.5% |
+4,480,000
| New | +$58.1M |
|
|
TGI
35
DELISTED
Triumph Group
TGI
| $58.3M | 0.49% |
+2,300,135
| New | +$53.2M |
|
|
36
PUT
Carnival Corporation Ltd
CCL
$39.7B
| $57.6M | 0.48% |
2,950,000
+1,750,000
| +146% | +$41.6M |
|
37
PUT
Avis
CAR
$5.02B
| $49.3M | 0.41% |
650,000
+460,000
| +242% | +$37M |
|
|
X
38
CALL
DELISTED
US Steel
X
| $48.5M | 0.41% |
1,148,800
-565,100
| -33% | -$21.4M |
|
39
Crown Holdings
CCK
$13.1B
| $47.3M | 0.4% |
530,000
-420,000
| -44% | -$36.6M |
|
40
Liberty Live Group Series A
LLYVA
$9.09B
| $41.4M | 0.35% |
615,000
+3,500
| +0.6% | +$244K |
|
41
PUT
Capital One
COF
$134B
| $36.8M | 0.31% |
205,000
+200,000
| +4,000% | +$37.8M |
|
42
The GEO Group
GEO
$4.04B
| $35.2M | 0.3% |
+1,205,000
| New | +$34.6M |
|
43
HCA Healthcare
HCA
$89.5B
| $32M | 0.27% |
+92,500
| New | +$29.8M |
|
|
44
PUT
HCA Healthcare
HCA
$89.5B
| $31.1M | 0.26% |
+90,000
| New | +$28.9M |
|
|
SWI
45
DELISTED
SolarWinds Corporation Common Stock
SWI
| $22.1M | 0.19% |
+1,201,358
| New | +$20.2M |
|
|
SWTX
46
DELISTED
SpringWorks Therapeutics
SWTX
| $22.1M | 0.19% |
+500,000
| New | +$23M |
|
47
PUT
Live Nation Entertainment
LYV
$42.1B
| $19.6M | 0.16% |
+150,000
| New | +$20.5M |
|
|
48
PUT
The GEO Group
GEO
$4.04B
| $19M | 0.16% |
+650,000
| New | +$18.6M |
|
|
49
PUT
Crown Holdings
CCK
$13.1B
| $17.9M | 0.15% |
200,000
-280,000
| -58% | -$24.4M |
|
50
PUT
TKO Group
TKO
$13.6B
| $16.8M | 0.14% |
110,000
-840,000
| -88% | -$128M |
|
Similar funds
CS
A
LF
MIM
SPIA
BPA
NAM
Pentwater Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pentwater Capital Management held 140 positions worth $11.9B, up 31% from $9.06B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Pentwater Capital Management deployed $2.52B of net new capital in Q1 2025, opening 48 new positions and adding to 33 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 9.2% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.2M trimmed.
- Pentwater Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.
- Pentwater Capital Management added most to Kellanova in Q1 2025, an estimated $184M increase.
- Pentwater Capital Management's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.2M.
- Pentwater Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $501M.
- Pentwater Capital Management's ten largest holdings make up 67% of its $11.9B portfolio in Q1 2025.
- Pentwater Capital Management opened 48 new positions and closed 39 in Q1 2025.
- Pentwater Capital Management's portfolio value rose 31% quarter-over-quarter to $11.9B.
Based on Pentwater Capital Management's 13F filing for Q1 2025, filed 15 May 2025.